defensin HNP-2 (Relief Therapeutics Holding)

N/A

Report date: 2025/03/18 18:18:57

Base Information

Drug Namedefensin HNP-2 (Relief Therapeutics Holding)
Drug Alias Namedefensin HNP-2 (THERAMetrics Holding)defensin human neutrophil peptide-2 (THERAMetrics Holding)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionAngiogenesis inhibitors
TargetsUpdating
Therapy Area/IndicationsAngiogenesis disorder
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRelief Therapeutics Holding AG
China Registration ClassN/A

Develop Information

Active CompaniesRelief Therapeutics Holding AG
Inactive CompaniesN/A
Active IndicationsAngiogenesis disorder
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A